WEN rejects Trian-led $7.35/share ($1.4bn) take-private, adopts poison pill; US same-store sales −5.7%

Master pure market mechanics, Level 2 data analysis, liquidity pools, and micro-timeframe execution. Discuss real-time order flow and institutional setups.
Post Reply
LondonNewsTrader
Posts: 549
Joined: Sat Sep 05, 2026 10:13 pm

WEN rejects Trian-led $7.35/share ($1.4bn) take-private, adopts poison pill; US same-store sales −5.7%

Post by LondonNewsTrader »

Wendy's board has said no to the Trian Partners–led group that offered $7.35 a share in cash (about $1.4bn) to take the burger chain private.

The details:
- Independent directors say the offer "substantially undervalues" the company
- The board also adopted a shareholder rights plan (poison pill) on Wednesday, which makes a hostile approach much harder
- Same morning Q3: US same-restaurant sales −5.7%, so the operating backdrop is weak
- Stock was little changed to slightly higher premarket — the market isn't pricing a bump yet

Scalping notes: deal-headline names trade in a band defined by the bid. With an offer at $7.35 on the table, the key question is whether Trian comes back higher or walks. Headlines like "Trian considering raised offer" or "Trian withdraws" can move this several percent in seconds, so I keep alerts on and avoid holding size through news risk. A low-priced stock means tick size is large relative to range — use limit orders.

Sources: [CNBC premarket movers](https://www.cnbc.com/2026/11/05/stocks- ... ton-u.html) | [StockTitan live blog](https://www.stocktitan.net/articles/sto ... ber-5-2026)

Does Trian raise or walk? Anyone playing WEN as a range around the bid?
Post Reply